Investigational Site Number : 4100008

Seoul, Seoul-teukbyeolsi 06591

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Pneumococcal Immunization

Studies at this site

• Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis — Running, not enrolling
• Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age — Running, not enrolling